Immune Reconstitution After Allogeneic Hematopoietic Stem Cell Transplantation and Association With Occurrence and Outcome of Invasive Aspergillosis.

BACKGROUND Invasive aspergillosis (IA) remains a leading cause of morbidity and mortality in patients receiving allogeneic hematopoietic stem cell transplantation (HSCT). To date, no reliable immunological biomarkers for management and outcome of IA exist. Here, we investigated reconstitution of antifungal immunity in patients during the first 12 months after HSCT and correlated it with IA. METHODS Fifty-one patients were included, 9 with probable/proven IA. We determined quantitative and qualitative reconstitution of polymorphonuclear (PMN), CD4, CD8, and natural killer (NK) cells against Aspergillus fumigatus over 5 time points and compared the values to healthy donors. RESULTS Absolute CD4 and CD8 cell counts, antigen-specific T-cell responses, and killing capacity of PMN against A. fumigatus were significantly decreased in all patients over 12 months. In patients with probable/proven IA, reactive oxygen species (ROS) production tended to be lower compared to patients without IA, and absolute NK-cell counts remained below 200 cells/µL. Patients with well-controlled IA showed significantly higher ROS production and NK-cell counts compared to patients with poor outcome. CONCLUSIONS This study highlights the importance of functional PMN, T-cell, and NK-cell immunity for the outcome of IA. Larger multicenter studies should address the potential use of NK-cell counts for the management of antifungal therapy.

[1]  M. Battegay,et al.  Multispecific Aspergillus T cells selected by CD137 or CD154 induce protective immune responses against the most relevant mold infections. , 2015, The Journal of infectious diseases.

[2]  H. Greinix,et al.  National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease , 2015 .

[3]  C. Solano,et al.  Serum galactomannan versus a combination of galactomannan and polymerase chain reaction-based Aspergillus DNA detection for early therapy of invasive aspergillosis in high-risk hematological patients: a randomized controlled trial. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  J. Camargo,et al.  Immune correlates of protection in human invasive aspergillosis. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  M. Robin,et al.  Favorable impact of natural killer cell reconstitution on chronic graft-versus-host disease and cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation , 2014, Haematologica.

[6]  E. Lagendijk,et al.  Induction of A. fumigatus-specific CD4-positive T cells in patients recovering from invasive aspergillosis , 2014, Haematologica.

[7]  Giovanni Apolone,et al.  Characterization of Specific Immune Responses to Different Aspergillus Antigens during the Course of Invasive Aspergillosis in Hematologic Patients , 2013, PloS one.

[8]  R. Hagedoorn,et al.  Characterization of the T-cell-mediated immune response against the Aspergillus fumigatus proteins Crf1 and catalase 1 in healthy individuals. , 2013, The Journal of infectious diseases.

[9]  S. Zimmermann,et al.  Natural Killer Cells and Antifungal Host Response , 2013, Clinical and Vaccine Immunology.

[10]  Deepali Kumar,et al.  State-of-the-art monitoring of cytomegalovirus-specific cell-mediated immunity after organ transplant: a primer for the clinician. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  G. Gastl,et al.  Invasive fungal breakthrough infections, fungal colonization and emergence of resistant strains in high-risk patients receiving antifungal prophylaxis with posaconazole: real-life data from a single-centre institutional retrospective observational study. , 2012, The Journal of antimicrobial chemotherapy.

[12]  H. Einsele,et al.  Human NK Cells Display Important Antifungal Activity against Aspergillus fumigatus, Which Is Directly Mediated by IFN-γ Release , 2011, The Journal of Immunology.

[13]  J. Latgé,et al.  Cross-protective TH1 immunity against Aspergillus fumigatus and Candida albicans. , 2011, Blood.

[14]  R. Landmann,et al.  TLR2 enhances NADPH oxidase activity and killing of Staphylococcus aureus by PMN. , 2011, Immunology letters.

[15]  J. Latgé,et al.  Human natural killer cells exhibit direct activity against Aspergillus fumigatus hyphae, but not against resting conidia. , 2011, The Journal of infectious diseases.

[16]  J. Staab,et al.  Healthy Human T-Cell Responses to Aspergillus fumigatus Antigens , 2010, PloS one.

[17]  Stephen R Cole,et al.  Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies , 2009, The Lancet.

[18]  T. Schoeb,et al.  Requisite Role for the Dectin-1 β-Glucan Receptor in Pulmonary Defense against Aspergillus fumigatus 1 , 2009, The Journal of Immunology.

[19]  M. Burdick,et al.  Early NK Cell-Derived IFN-γ Is Essential to Host Defense in Neutropenic Invasive Aspergillosis1 , 2009, The Journal of Immunology.

[20]  R. Strieter,et al.  Early NK Cell-Derived Interferon-Gamma Is Essential to Host Defense in Neutropenic Invasive Aspergillosis. , 2009, ATS 2009.

[21]  M. Pfreundschuh,et al.  Levels of CMV Specific CD4 T Cells Are Dynamic and Correlate with CMV Viremia after Allogeneic Stem Cell Transplantation , 2008, PloS one.

[22]  K. Marr.  Fungal infections in hematopoietic stem cell transplant recipients. , 2008, Medical mycology.

[23]  W. Nauseef.  How human neutrophils kill and degrade microbes: an integrated view , 2007, Immunological reviews.

[24]  J. Orange.  Human natural killer cell deficiencies , 2006, Current opinion in allergy and clinical immunology.

[25]  J. O'connor,et al.  Killed Candida albicans Yeasts and Hyphae Inhibit Gamma Interferon Release by Murine Natural Killer Cells , 2006, Infection and Immunity.

[26]  Daniel Wolff,et al.  National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report. , 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[27]  M. Richardson,et al.  Changing patterns and trends in systemic fungal infections. , 2005, The Journal of antimicrobial chemotherapy.

[28]  D. Kontoyiannis,et al.  Aspergillus fumigatus suppresses the human cellular immune response via gliotoxin-mediated apoptosis of monocytes. , 2005, Blood.

[29]  L. Romani.  Immunity to fungal infections , 2004, Nature Reviews Immunology.

[30]  B. Morrison,et al.  Chemokine-mediated recruitment of NK cells is a critical host defense mechanism in invasive aspergillosis. , 2003, The Journal of clinical investigation.

[31]  J. Latgé,et al.  Analysis of T-cell responses to Aspergillus fumigatus antigens in healthy individuals and patients with hematologic malignancies. , 2002, Blood.

[32]  Lawrence Corey,et al.  Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[33]  E D Thomas,et al.  1994 Consensus Conference on Acute GVHD Grading. , 1995, Bone marrow transplantation.

[34]  S. Bhakdi,et al.  Susceptibility testing of Candida albicans and Aspergillus species by a simple microtiter menadione-augmented 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide assay , 1995, Journal of clinical microbiology.

[35]  D. Venzon,et al.  Prevention of corticosteroid-induced suppression of human polymorphonuclear leukocyte-induced damage of Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and gamma interferon , 1993, Infection and immunity.

[36]  C. Sellitto,et al.  Interleukin-2 and increased natural killer activity in mice experimentally infected with Aspergillus niger. , 1988, Microbiologica.

[37]  M. I. Jayson,et al.  Prednisolone inhibits phagocytosis by polymorphonuclear leucocytes via steroid receptor mediated events , 1983, Annals of the rheumatic diseases.

[38]  R. Clark,et al.  Damage to Aspergillus fumigatus and Rhizopus oryzae Hyphae by Oxidative and Nonoxidative Microbicidal Products of Human Neutrophils In Vitro , 1982, Infection and immunity.

[39]  E. Lagendijk,et al.  Induction of A . fumigatus-specific CD 4 + T-cells in patients recovering from invasive aspergillosis by , 2014 .

[40]  S. Cole,et al.  Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients : a collaborative analysis of 18 HIV cohort studies , 2009 .

[41]  M. Turner,et al.  National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. , 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[42]  D. Denning,et al.  Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[43]  J. Ashwell,et al.  Glucocorticoids in T cell development and function*. , 2000, Annual review of immunology.